Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3546 |
|
| Actual shortage: | 240 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3292 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-04-26 | 2024-06-28 | 226336 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-05-31 | 2024-06-28 | 229413 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-07-12 | 2024-07-26 | 232826 |
| APO-PRAZO | 1MG | TABLET | Resolved | 2018-01-18 | 2018-06-12 | 36441 |
| APO-PRAZO | 1MG | TABLET | Resolved | 2019-02-24 | 2019-04-08 | 76732 |
| APO-PRAZO | 1MG | TABLET | Resolved | 2020-04-13 | 2020-06-22 | 111946 |
| APO-PRAZO | 1MG | TABLET | Resolved | 2023-01-20 | 2025-03-12 | 181967 |
| APO-PRAZO | 2MG | TABLET | Resolved | 2017-11-28 | 2018-01-29 | 31019 |
| APO-PRAZO | 2MG | TABLET | Resolved | 2020-09-02 | 2020-10-16 | 123574 |
| APO-PRAZO | 2MG | TABLET | Resolved | 2023-04-06 | 2025-03-12 | 188943 |
| APO-PRAZO | 5MG | TABLET | Resolved | 2018-03-13 | 2018-06-12 | 42700 |
| APO-PRAZO | 5MG | TABLET | Resolved | 2018-11-21 | 2019-03-26 | 67409 |
| APO-PRAZO | 5MG | TABLET | Resolved | 2020-04-15 | 2020-06-22 | 112192 |
| APO-PRAZO | 5MG | TABLET | Resolved | 2020-08-12 | 2020-10-19 | 122074 |
| APO-PRAZO | 5MG | TABLET | Resolved | 2022-12-09 | 2023-01-20 | 177594 |
| APO-PRAZO | 5MG | TABLET | Resolved | 2023-03-02 | 2025-03-12 | 185924 |
| APO-PREGABALIN | 150MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 447 |
| APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 450 |
| APO-PREGABALIN | 75MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 456 |
| APO-PREGABALIN | 25MG | CAPSULE | Resolved | 2017-03-12 | 2017-10-10 | 728 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |